Evidence map›Paper›PMID 41791447›Full record

ArticleAnalytical biochemistry2026

Efficient tag-less purification of recombinant human tau proteins.

Joseph A Pettis, Mason Orshoski, Sonali Pal, Austin M Allen, Martha Ortega Zepeda, Vicki H Wysocki, Jeff Kuret

Abstract read
In one paragraph

Article in Analytical biochemistry, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Article
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Joseph A PettisOhio State Biochemistry Program, The Ohio State University, Columbus, OH, 43210, USA.
Mason OrshoskiDepartment of Biological Chemistry and Pharmacology, The Ohio State University, Columbus, OH, 43210, USA.
Sonali PalOhio State Biochemistry Program, The Ohio State University, Columbus, OH, 43210, USA.
Austin M AllenDepartment of Biological Chemistry and Pharmacology, The Ohio State University, Columbus, OH, 43210, USA.
Martha Ortega ZepedaDepartment of Chemistry and Biochemistry, The Ohio State University, Columbus, OH, 43210, USA.
Vicki H WysockiDepartment of Chemistry and Biochemistry, The Ohio State University, Columbus, OH, 43210, USA.
Jeff KuretDepartment of Biological Chemistry and Pharmacology, The Ohio State University, Columbus, OH, 43210, USA. Electronic address: kuret.3@osu.edu.

Funding

Interdisciplinary Research Network on Biologically Active Tau Aggregate Polymorphs from Alzheimer's Disease and Related DementiasU24AG072458 · NIA · UNIVERSITY OF TEXAS MED BR GALVESTON · PI EISENBERG, DAVID, KAYED, RAKEZ · 2021 to 2025
$7.8M
Structure and Genesis of tau AggregatesRF1AG054018 · NIA · OHIO STATE UNIVERSITY · PI KURET, JEFF · 2017 to 2022
$4.4M
Structure and Genesis of tau AggregatesR01AG054018 · NIA · OHIO STATE UNIVERSITY · PI Jeff Kuret · 2025 to 2026
$1.2M
NIA NIH HHS R01 AG054018NIA NIH HHS RF1 AG054018NIA NIH HHS U24 AG072458
6 · The paper itself

Abstract

Tau proteins normally function as part of the neuronal cytoskeleton but aggregate to form filamentous inclusions in tauopathies such as Alzheimer's disease. The diverse functions of tau protein are frequently interrogated using biochemical assays that require highly purified tau as substrate. Conventional recombinant tau purification leverages polyhistidine (His6) tags to enable rapid and efficient isolation through immobilized metal affinity chromatography (IMAC). Preparation of native tau by this approach requires removal of His6 tags through additional processing steps. Here we report a protocol for purifying native recombinant full-length tau protein that retains the speed, convenience, broad availability and scalability of IMAC while eliminating the need for post-purification proteolytic cleavage. The method has been validated across a wide array of tau constructs, including full-length isoforms, missense mutants, and a truncation construct containing an aggregation-prone region of the microtubule-binding domain. Owing to its scalability and reproducibility, the method is well suited for structure-activity relationship investigations involving curated tau variant libraries.

Indexed as

Chromatography, Affinitytau ProteinsHistidineHumansRecombinant ProteinsHistidineRecombinant Proteinstau ProteinsHydrodynamicsImmobilized metal affinity chromatographyIntrinsically disordered structureProtein purificationTau

Identifiers

PMID41791447
PMCPMC13264810

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.